IL1B and COVID-19: We first selected IL‐1β, as it was produced by LPS‐treated, LPS‐primed virus‐exposed and virus primed LPS‐exposed MDM (Fig 6G, H, O and P) and has been observed in severe COVID‐19 patient lungs (Laing et al, 2020; Rodrigues et al, 2021).